Authentication of the 31 species of toxic and potent chinese materia medica by microscopic technique assisted by ICP‐MS analysis, part 4: Four kinds of toxic and potent mineral arsenical CMMs
暂无分享,去创建一个
Zhong-Zhen Zhao | Qin Li | Qin Li | Chu Chu | Ya‐Qiong Wang | Hu‐Biao Chen | Ping Li | Zhong‐Zhen Zhao | Chu Chu | Hu-Biao Chen | Ping Li | Ya-qiong Wang
[1] O. Ogawa,et al. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine , 2004, Cell Death and Differentiation.
[2] G. Golding,et al. Public Health Risks from Heavy Metals and Metalloids Present in Traditional Chinese Medicines , 2007, Journal of toxicology and environmental health. Part A.
[3] M. Fu,et al. Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo. , 2007, Gynecologic oncology.
[4] B. Jiang,et al. Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report. , 2002, Blood.
[5] Sun Gui-fan. Determination of As(III) Content in Realgar by HPLC-HG-AFS , 2008 .
[6] Li Xia,et al. Authentication of the 31 species of Toxic and Potent Chinese Materia Medica (T/PCMM) by microscopic technique, part 2: Three species of seed T/PCMM , 2008, Microscopy research and technique.
[7] W. D. Nesse,et al. Introduction to optical mineralogy , 1986 .
[8] E. W. Heinrich. Microscopic Identification of Minerals , 1965 .
[9] Ling Yi,et al. Authentication of the 31 species of toxic and potent Chinese Materia medica (T/PCMM) by microscopic technique, part 1: Three kinds of toxic and potent animal CMM , 2007, Microscopy research and technique.
[10] I. Koch,et al. Bioaccessibility and excretion of arsenic in Niu Huang Jie Du Pian pills. , 2007, Toxicology and applied pharmacology.
[11] Zhi-xiang Shen,et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia , 2008, Proceedings of the National Academy of Sciences.
[12] Kathleen Shordt,et al. Arsenic in drinking water. , 2001, Journal of environmental health.
[13] Wei Tang,et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. , 1997, Blood.
[14] V. B. Konkimalla,et al. From traditional Chinese medicine to rational cancer therapy. , 2007, Trends in molecular medicine.
[15] Z. Dong-sheng. Effect of Orpiment Nanoparticles on Telomerase Activity in K562 Cell Line , 2007 .
[16] Janet S. Lee,et al. Mechanisms of action of arsenic trioxide. , 2002, Cancer research.
[17] K. Hede. Chinese folk treatment reveals power of arsenic to treat cancer, new studies under way. , 2007, Journal of the National Cancer Institute.
[18] C. China Pharmacopoeia,et al. Pharmacopoeia of the People's Republic of China , 2010 .
[19] C. Gribble,et al. Optical Mineralogy : Principles And Practice , 1993 .
[20] Zhong-Zhen Zhao,et al. Authentication of the 31 species of toxic and potent Chinese Materia Medica by light microscopy, part 3: Two species of T/PCMM from flowers and their common adulterants , 2009, Microscopy research and technique.
[21] M. Tallman,et al. The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future. , 2004, Leukemia research.
[22] S. Aronson. Arsenic and old myths. , 1994, Rhode Island medicine.
[23] E. Ernst. Toxic heavy metals and undeclared drugs in Asian herbal medicines. , 2002, Trends in pharmacological sciences.
[24] T. Ley,et al. Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. , 2001, Blood.